Doctor profile · Federal record
Dr. Rasa Kazlauskaite, MD, MSC, FACE
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Chicago, IL
- NPI 1487609954
- Accepts Medicare
- 35 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1700 W van Buren St, Suite 470
Chicago, IL 606125500
(312) 942-3227
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- September 29, 2011
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Illinois #036-096791
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1487609954. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
795
Distinct HCPCS
6
Medicare allowed
$100,080
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 472 | 207 | $127 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 123 | 122 | $183 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 98 | 24 | $34 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 69 | 41 | $190 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 22 | 15 | $36 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 11 | 11 | $54 |
In context: peer comparison
Among 41 peers in this city , average services per provider: 186. This provider delivers 4.3× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
350
Patients
45
Total drug cost
$132,769
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 75 | 22 | $1,266 |
| Ozempic (Semaglutide) | Brand | 49 | 12 | $79,739 |
| Atorvastatin Calcium | Generic | 38 | 11 | $529 |
| Metformin Hcl | Generic | 26 | 0 | $531 |
| Alendronate Sodium | Generic | 23 | 0 | $291 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 19 | 0 | $17,509 |
| Nateglinide | Generic | 17 | 0 | $1,899 |
| Rosuvastatin Calcium | Generic | 15 | 0 | $479 |
| Allopurinol | Generic | 14 | 0 | $168 |
| Amlodipine Besylate | Generic | 13 | 0 | $243 |
Hospital affiliations
Frequently asked questions
What is Dr. Rasa Kazlauskaite's medical specialty?
Dr. Rasa Kazlauskaite practices Endocrinology, Diabetes & Metabolism Physician in Chicago, IL.
Where does Dr. Rasa Kazlauskaite practice?
Dr. Rasa Kazlauskaite practices at 1700 W van Buren St, Chicago, IL 606125500. Office phone: 3129423227.
What is Dr. Rasa Kazlauskaite's NPI?
Dr. Rasa Kazlauskaite's National Provider Identifier (NPI) is 1487609954, issued by NPPES.
Does Dr. Rasa Kazlauskaite accept Medicare assignment?
Yes. Dr. Rasa Kazlauskaite accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rasa Kazlauskaite commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Initial hospital care with moderate level of medical decision making (HCPCS 99223); Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS G2212). Source: CMS Medicare Physician & Other Practitioners file.